Brook Girma, MD
Anesthesiology · Portland, ORNPI 1437610623
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (51.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 78.7% of it on its own, with 7 other manufacturers making up the rest. Among anesthesiology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $185.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Medtronic$510
- Nevro Corp.$481
- Saluda Medical Americas, Inc.$257
- Merck$58
- Averitas Pharma Inc.$36
- plus $38 from 2 others
What the payments were for
- Grants$3,33351%
- Travel & lodging$1,79828%
- Food & beverage$1,36921%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $5,118 |
| Medtronic | 7 | $510 |
| Nevro Corp. | 7 | $481 |
| Saluda Medical Americas, Inc. | 6 | $257 |
| Merck | 3 | $58 |
| Averitas Pharma Inc. | 1 | $36 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$4,936
- INTELLIS ADAPTIVESTIM$288
- Senza$263
- Evoke SCS$137
How this compares
$6,500 in reported general payments places this provider in the 95th percentile of 691 anesthesiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 18 | $1,320 |
| Gabapentin | 31 | $364 |
| Baclofen | 12 | $156 |
| Meloxicam | 61 | $138 |
| Methocarbamol | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Portland
- Shawn SchumacherPortland$82K
- Neesa PatelPortland$41K
- Andrea OrfanakisPortland$10K
- Michael AzizPortland$8K
- Michael HutchensPortland$6K
- Alexander WoodrowPortland$5K
- Bryan MaxwellPortland$4K
- James WatkinsPortland$4K
- Derick du VivierPortland$4K
- Zheyan ChenPortland$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.